Legal experts say Congress should give FDA new power to respond to shortages of critical drugs, floating the ideas of letting FDA temporarily re-purpose a drug license to another company, akin to NIH's march-in rights, and allowing importation from unregistered foreign manufacturers.
http://healthpolicynewsstand.com/
No comments:
Post a Comment